2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 96.0%, 250mg

(1R,2R)-1-((TERT-BUTOXYCARBONYL)AMINO)-2-(DIFLUOROMETHYL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 250mg

N4-ACETYL-2'-FLUORO-2'-DEOXYCYTIDINE, 95.0%, 1g

Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2,3-dihydro-3-oxo-1,2-benzisoxazol-6-yl)Methoxy]-, 10mg

4-Bromo-2-fluoro-1-(methylsulfonyl)benzene, 95.0%, 1g

2-(Benzofuran-3-yl)acetic acid, 95.0%, 1g

(5-Aminopyridin-2-yl)dimethylphosphine oxide, 98%, 50mg

2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE HYDROCHLORIDE, 95%, 10g

1,2-Propanediol, min 99,5%, Ph.Eur., 1 l, emballage plastique.

4,4,5,5-Tetramethyl-2-tetrahydrofuran-2-yl-1,3,2-dioxaborolane, 98%, 250mg

1-(6-Bromopyridin-3-yl)ethanone, 97.0%, 500g

2-Méthylimidazole, >=98%, pour la synthèse, 100 g, emballage en verre

4-Propylaniline, 95.0%, 25g